Reported research findings
- Human clinical evidence is limited to date; the strongest data comes from preclinical models.
LONGEVITY & METABOLIC RESEARCH
MOTS-C
A mitochondrial-derived peptide studied as a metabolic regulator and exercise mimetic.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide studied as a metabolic regulator and “exercise mimetic.” It has a well-defined AMPK-activation mechanism, with evidence to date primarily preclinical.
Why BLP features MOTS-C
Included because it has a specific, well-defined mitochondrial mechanism (AMPK activation) and compelling preclinical metabolic data. Human clinical evidence remains limited, so it is presented as experimental despite growing research interest.
Mechanism
Translocates into the nucleus to regulate gene expression.
Activates the AMPK pathway, increasing fat oxidation and insulin sensitivity.
Boosts mitochondrial biogenesis and glucose uptake, mimicking exercise effects at the cellular level.
WHAT THE RESEARCH MEASURED
Research findings
Findings describe study outcomes, not expected personal results.
Preclinical findings
- In models: reported fat loss (especially lower abdomen), improved insulin sensitivity, and better blood-sugar control.
- Reported increased endurance and training capacity.
- Reported anti-aging effects on metabolism and muscle.
- Extremely well tolerated in research use.
Regulatory status
MOTS-C is investigational with primarily preclinical evidence. Sold and offered strictly for laboratory and research use.